About Fortrea
Fortrea is a publicly listed company based in Durham (United States) founded in 2015. It operates as a provider of early late phase clinical development, market access, and HEOR strategy services. The company has 15,500 employees. Its website fortrea.com draws about 89 thousand monthly visits. Its focus areas include Biopharma Outsourcing and Diversified. Its competitors include Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals and 4 more; 3 of its 9 listed competitors have raised funding.
Company details
Fortrea was established in 2015 and is headquartered in Durham, United States. Operations focus on the clinical research and healthcare sectors, where early and late phase clinical development services are delivered alongside market access solutions and health economics and outcomes research (HEOR) strategies. These offerings support pharmaceutical and biotech clients in navigating development pipelines and reimbursement processes across global markets.
- Annual Revenue$2.72 B (USD)1as on Dec 31, 2025
- Net Profit-$986.2 M (USD)-219.26as on Dec 31, 2025
- EBITDA$47.4 M (USD)0as on Dec 31, 2025
- Employee Count15,500
Apps and channels of Fortrea
its YouTube channel Fortrea has 655 subscribers and 30 videos.
Videos from Fortrea
The most watched videos on Fortrea's YouTube channel, Fortrea (655 subscribers). Click a video to play it here.
More on Fortrea.
People of Fortrea
499 people are tracked at Fortrea (149 in leadership, 350 in team); the tracked headcount is 15,500.
| Name | Role | Group |
|---|---|---|
Priyank Sameer | IT Strategic Planning Analyst, Office Of The Chief Information Officer (ocio) | Leadership |
Dana Glisson | Vice President, Site Readiness And Regulatory | Leadership |
Patty Openshaw | Associate Director, Clinical Systems Operational Support | Leadership |
Todd Altieri | Executive Director, Global Head Of Commercial Development GCD | Leadership |
Robert Beaumont | Director, IT Quality And Compliance | Leadership |
Melanie Pike | Associate Director Technical Design | Leadership |
Mark Lovern | Executive Director, Medical Science Services | Leadership |
Dinesh Mistry | Executive Director: Global Regulatory Affairs Strategy | Leadership |
Ashlyn Ee | Director Clinical Management APAC | Leadership |
Gemba Takefumi | Executive Director, Global Regulatory Affairs | Leadership |
Therfena N. Green | Associate Director, Clinical Data Management | Leadership |
Phil Williams | Senior Director, Strategic Partnerships | Leadership |
Donna Little | Vice President, Clinical Network | Leadership |
Daniela Parkinson | Director, Clinical Operations Phase 1 Monitoring Services | Leadership |
Vithi Trivedi | Director Project Delivery | Leadership |
Bobby Parks | Chief Accounting Officer | Leadership |
Corum McNealy | Vice President, Global Head Of Commercial Solutions And Strategic Deals | Leadership |
Brandi Bonner | Associate Director Site Readiness | Leadership |
Matthew Whitehouse | Senior Director, Clinical Management | Leadership |
Kazuya Iwamoto | Senior Medical Director | Leadership |
479 more people are available in the full profile.
Complete people profiles for Fortrea
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Fortrea
Fortrea is a publicly listed company on the NASDAQ with ticker symbol FTRE in USA, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date07 Jul 2023
- Listed onNASDAQ: FTRE
- Listed entityFortrea Holdings Inc.
- Exchange sectorCommercial services
- ISINUS34965K1079
- Share price$20.92 (-0.38% on the day) · 2026-10-13
- Market capitalisation$1.99B
- EPS (diluted, trailing year)$-0.92
- Volume (last session)764,311
Financials of Fortrea
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $2.72B | -$986.2M | $47.4M |
| 2024 | $2.70B | -$308.9M | -$26.5M |
| 2023 | $2.84B | -$25.2M | $142.5M |
| 2022 | $3.10B | $192.9M | $393.8M |
| 2021 | $3.06B | $98.0M | $333.8M |
Detailed financial statements for Fortrea
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Fortrea
Fortrea has 9 listed competitors in our database, 3 of them funded. They include Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| eurofins.com | 1987 | Luxembourg | – | – | Laboratory testing and contract research services are provided globally. | |
| wuxiapptec.com | 2000 | Shanghai, China | $40M | 1,681 | Provider of CRO and CDMO services | |
| ipsen.com | 1929 | – | – | 505 | Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes | |
| cheplapharm.com | 1998 | Mesekenhagen, Germany | – | 840 | Branded pharmaceutical products are developed, marketed, and distributed globally. | |
| anipharmaceuticals.com | 1996 | Baudette, United States | – | 600 | Branded and generic prescription drugs are developed, manufactured, and marketed. | |
| caidya.com | 2003 | Morrisville, United States | $373M | 351 | CRO focused on clinical development for phases II & III clinical trials and regulatory affair services | |
| rednucleus.com | 2014 | Yardley, United States | – | 176 | Advisory, scientific, and medical communications provided for pharmaceutical industry. | |
| aptar.com | 1992 | Crystal Lake, United States | – | 232 | Regulatory support, brand differentiation, and prototyping services are provided. | |
| aliadatx.com | 2021 | Boston, United States | $33M | – | Provider of drug research & development services for multiple therapeutic areas |
Detailed competitors of Fortrea
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Fortrea
The website of Fortrea (fortrea.com) receives about 88.5K visits a month and ranks #424,197 among all websites worldwide, #380 in Biotechnology and Pharmaceuticals.
- Monthly visits88.5K
▲ 15.2% vs previous month
- Unique visitors34.8K
per month
- Global rank#424,197
among all websites
- Category rank#380
Health · Biotechnology and Pharmaceuticals
- Bounce rate41%
- Pages per visit2.7
- Average visit51 sec
- DevicesDesktop 31% · Mobile 69%
Websites whose visitors overlap most with Fortrea. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
fortreaclinicaltrials.com | fortreaclinicaltrials.com | 100% | – | #284,908 | – |
| syneoshealth.com | 82% | 199.6K | #198,509 | View details | |
| worldwide.com | 79% | 89.1K | #546,596 | View details | |
| medidata.com | 78% | 87K | #373,122 | View details | |
| ppd.com | 74% | 226.8K | #271,623 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for Fortrea
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Fortrea (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Fortrea
Complete news archive for Fortrea
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fortrea
Fortrea was founded in 2015.
Fortrea is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Fortrea has 15,500 employees.
Annual revenue of Fortrea is $2.72B as on Dec 31, 2025.
Fortrea was established in 2015 and is headquartered in Durham, United States. Operations focus on the clinical research and healthcare sectors, where early and late phase clinical development services are delivered alongside market access solutions and health economics and outcomes research (HEOR) strategies. These offerings support pharmaceutical and biotech clients in navigating development pipelines and reimbursement processes across global markets.
Fortrea's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
Yes, Fortrea is publicly traded on NASDAQ under the ticker symbol FTRE.